BSEInsider Trading / SAST23 Jun 2026 · 23 Jun 2026, 04:04 pm
Intimation of Closure of Trading window for the quarter ended June 30, 2026
Godavari Drugs Ltd · 530317
✦ AI Summary
Godavari Drugs Ltd has announced the closure of its trading window for Designated Persons and their immediate relatives from July 1, 2026, until 48 hours after the declaration of un-audited financial results for the quarter ending June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent insider trading ahead of financial disclosures.
Analysis Scores
Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Godavari Drugs Ltd - 530317 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
bb0d7da0-6df7-402a-b69e-c19c075675aa.pdf
View document text
GODAVARI DRUGS LIMITED
Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India.
Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557
E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com
23.06.2026
CORPORATE RELATIONS DEPARTMENT,
BSE LIMITED
PHIROZE JEEJEEBHOY TOWERS
DALAL STREET, MUMBAI- 400 001
Sub: Intimation of closure of trading window in terms of SEBI (Prohibition of Insider Trading
Regulations, 2015
Scrip code: 530317
Dear Sir,
It is hereby informed that pursuant to the provisions of Securities and Exchange Board of India
(Prohibition of Insider Trading) Regulation, 2015 read with Code of Conduct for Regulating,
Monitoring and Reporting of Trading by Designated Persons as framed by the Company, the
trading window for dealing in securities of the Company will remain closed for all Designated
Persons and their immediate relatives from July 1, 2026 till 48 hours after declaration of the un-
audited financial results of the Company for the quarter ending June 30, 2026 by the Company to
the Stock Exchange.
Accordingly all Connected/ Designated Persons and their relatives have been advised not to trade
in the securities of the Company during the aforesaid period of closure of trading window.
This is for your information and record. Thanking you.
Thanking You
Yours Sincerely
For Godavari Drugs Limited
Venkatesh Achanta
Company Secretary & Compliance Officer
Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.com CIN:L24230TG1987PLC008016